Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism
Status:
Terminated
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
Men with idiopathic hypogonadotropic hypogonadism (IHH, Kallmann Syndrome) may have small
testicular size, low testosterone levels, no history of puberty, and infertility. These men
lack a hormone called gonadotropin releasing hormone (GnRH) that stimulates the development
and maturation of the testes. This study will investigate the impact of hormonal treatments
on men with IHH. The goal of hormonal therapy is to maximize the potential fertility in these
individuals.
Phase:
Phase 2
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)